Tetraciklin

Tetraciklin
(IUPAC) ime
	(4S,6S,12aS)-4-(dimetilamino)-1,4,4a,5,5a,6,11,12a-oktahidro-3,6,10,12,12a-pentahidroksi-6-metil-1,11-dioksonaftacen-2-karboksamid ; ili; (4S,6S,12aS)-4-(dimetilamino)-3,6,10,12,12a-pentahidroksi-6-metil-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidrotetracene-2-karboksamid
Klinički podaci
Robne marke	Sumicin
AHFS/Drugs.com	Monografija
MedlinePlus	a682098
Identifikatori
CAS broj	60-54-8 ; 64-75-5 (hidrohlorid)
ATC kod	A01AB13 D06AA04 J01AA07 S01AA09 S02AA08 S03AA02 QG01AA90 QG51AA02 QJ51AA07
PubChem	643969
DrugBank	DB00759
ChemSpider	10257122
UNII	F8VB5M810T
KEGG	D00201
ChEBI	CHEBI:27902
ChEMBL	CHEMBL1440
Hemijski podaci
Formula	C22H24N2O8
Mol. masa	444,435 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25,27-28,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1 ; Key: OFVLGDICTFRJMM-WESIUVDSSA-N
Farmakokinetički podaci
Bioraspoloživost	60-80% oralno, pri postu; <40% intramuskularno
Metabolizam	ne metabolizuje se
Poluvreme eliminacije	6-11 sati
Izlučivanje	Fekalno ili renalno
Farmakoinformacioni podaci
Licenca	US FDA:link
Trudnoća	D(AU) D(US)
Pravni status	℞ Prescription only
Način primene	oralno, topikalno (koža i oči), intramaskularno, intravenozno

Tetraciklin je poliketidni antibiotik širokog spektra koji proizvodi Streptomyces rod aktinobakterija.^[6]^[7] On se koristi protiv mnogih bakterijskih infekcija. Tetraciklin je inhibitor proteinske sinteze. On se često koristi za tretman akni, i od nedavno rozaceja. Istorijski ovaj lek je imao važnu ulogu u redukovanju smrtnosti usled kolere. Tetraciklin je u prodaji pod mnoštvom imenima, neka od kojih su: Sumycin, Tetracyn, i Panmycin. On se takođe koristi u proizvodnji nekoliko semisintetičkih derivata, koji su poznati kao tetraciklinski antibiotici. Termin tetraciklin se takođe koriti za označavanje sistema sa četiri prstena ovog jedinjenja. Tetraciklini su srodne supstance koje sadrže sistem sa četiri prstena.

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11 izd.). New York: McGraw-Hill. ISBN 0-07-142280-3.
↑ Pdr Staff (2009). PDR: Physicians Desk Reference 2010 (Physicians' Desk Reference (Pdr)). Rozelle, N.S.W: Thomson Reuters. ISBN 1-56363-748-0.

Vanjske veze

	Portal Medicina
	Portal Hemija

Tetracycline bound to proteins in the PDB

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11 izd.). New York: McGraw-Hill. ISBN 0-07-142280-3.

[7] Pdr Staff (2009). PDR: Physicians Desk Reference 2010 (Physicians' Desk Reference (Pdr)). Rozelle, N.S.W: Thomson Reuters. ISBN 1-56363-748-0.

[6]

[7]

[1]

[2]

[3]

[4]

[5]